{"rows":[{"id":5951,"title":"Acute psilocybin or ethocybin leads to a sustained increase in Pavlovian aversion memory in male mice","authors":"Hogg D, Romanos J, Albiez J, Hofer C, Wicki S, Argunşah A, Sigrist H, Thomann J, Luethi D, Vollenweider F, Pryce C.","journal":"Frontiers in pharmacology","publication_date":"2026-10-07","publication_year":2026,"doi":"10.3389/fphar.2026.1918182","pubmed_id":null,"openalex_id":"https://openalex.org/W7213965271","source_url":"https://europepmc.org/article/PMC/PMC13639876","substance_tags":"psilocybin","topic_tags":"Animal Study","study_type":"Animal Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-23 01:20:24","last_checked":"2026-10-14 01:20:30","bibtex":null,"source_record_id":"DOI:10.3389/fphar.2026.1918182","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://europepmc.org/article/PMC/PMC13639876","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"DOI:10.3389/fphar.2026.1918182","source_url":"https://europepmc.org/article/PMC/PMC13639876","doi":"10.3389/fphar.2026.1918182","pmid":"","publication_date":"2026-10-07","importer_version":"2.1.3","text_redistributed":false}},{"id":5437,"title":"177. NMDA and 5-HT2A receptor dysfunction in working memory deficits in schizophrenia","authors":"Daniel Umbricht, F.X. Vollenweider, L. Schmid, R. Koller","journal":"Biological Psychiatry","publication_date":"2000-03-31","publication_year":2000,"doi":"10.1016/s0006-3223(00)00439-x","pubmed_id":null,"openalex_id":"https://openalex.org/W2104342516","source_url":"https://doi.org/10.1016/s0006-3223(00)00439-x","substance_tags":"psilocybin","topic_tags":"Pharmacology,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:07","last_checked":"2026-07-04 06:52:07","bibtex":null,"source_record_id":"DOI:10.1016/s0006-3223(00)00439-x","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/s0006-3223(00)00439-x","source_url":"https://doi.org/10.1016/s0006-3223(00)00439-x","doi":"10.1016/s0006-3223(00)00439-x","pmid":"","publication_date":"2000-03-31","importer_version":"2.1.3","text_redistributed":false}},{"id":5427,"title":"A double-blind, placebo controlled study of the effect of the hallucinogenic 5-HT1A&2A agonist psilocybin on binocular rivalry rate and rhythmicity","authors":"O. Carter, Shaun P. Collin, Felix Hasler, George Liu, Franz X. Vollenweider, John D. Pettigrew","journal":"Social Neuroscience","publication_date":"2003-01-01","publication_year":2003,"doi":null,"pubmed_id":null,"openalex_id":"https://openalex.org/W77944008","source_url":"https://espace.library.uq.edu.au/view/UQ:161618","substance_tags":"psilocybin","topic_tags":"Pharmacology,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:07","last_checked":"2026-08-09 08:25:56","bibtex":null,"source_record_id":"https://espace.library.uq.edu.au/view/UQ:161618","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"https://espace.library.uq.edu.au/view/UQ:161618","source_url":"https://espace.library.uq.edu.au/view/UQ:161618","doi":"","pmid":"","publication_date":"2003-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5422,"title":"P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosis","authors":"Felix Hasler, Ulrike Grimberg, Martin Benz, F.X. Vollenweider","journal":"European Neuropsychopharmacology","publication_date":"2003-10-01","publication_year":2003,"doi":"10.1016/s0924-977x(03)92355-8","pubmed_id":null,"openalex_id":"https://openalex.org/W2051778190","source_url":"https://doi.org/10.1016/s0924-977x(03)92355-8","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Pharmacology,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:06","last_checked":"2026-08-09 08:25:56","bibtex":null,"source_record_id":"DOI:10.1016/s0924-977x(03)92355-8","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/s0924-977x(03)92355-8","source_url":"https://doi.org/10.1016/s0924-977x(03)92355-8","doi":"10.1016/s0924-977x(03)92355-8","pmid":"","publication_date":"2003-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5419,"title":"The Effects of he Hallucinogenic Serotonin 1A/2A Agonist, Psilocybin, on Binocular Rivalry and Visual Contrast Detection Thresholds","authors":"O. Carter, David Alais, David C. Burr, Felix Hasler, G. Liu, Guy Wallis, Franz X. Vollenweider, John D. Pettigrew","journal":"Queensland's institutional digital repository (The University of Queensland)","publication_date":"2003-12-31","publication_year":2003,"doi":null,"pubmed_id":null,"openalex_id":"https://openalex.org/W111026355","source_url":"https://openalex.org/W111026355","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:06","last_checked":"2026-07-04 06:52:06","bibtex":null,"source_record_id":"https://openalex.org/W111026355","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"https://openalex.org/W111026355","source_url":"https://openalex.org/W111026355","doi":"","pmid":"","publication_date":"2003-12-31","importer_version":"2.1.3","text_redistributed":false}},{"id":5367,"title":"Effects of the hallucinogenic 5-HT2A agonist psilocybin on object completion in humans","authors":"F.X. Vollenweider, Daniel Hell, Michael Kometer","journal":"International Journal of Psychophysiology","publication_date":"2008-07-17","publication_year":2008,"doi":"10.1016/j.ijpsycho.2008.05.397","pubmed_id":null,"openalex_id":"https://openalex.org/W1965548601","source_url":"https://doi.org/10.1016/j.ijpsycho.2008.05.397","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:05","last_checked":"2026-08-09 08:25:55","bibtex":null,"source_record_id":"DOI:10.1016/j.ijpsycho.2008.05.397","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.ijpsycho.2008.05.397","source_url":"https://doi.org/10.1016/j.ijpsycho.2008.05.397","doi":"10.1016/j.ijpsycho.2008.05.397","pmid":"","publication_date":"2008-07-17","importer_version":"2.1.3","text_redistributed":false}},{"id":5346,"title":"Using psilocybin to investigate the relationship between attention, working memory and the serotonin 5-HT1A and 5-HT2A receptors","authors":"Olivia Carter, David C. Burr, John D. Pettigrew, Franz X. Vollenweider","journal":"Journal of Vision","publication_date":"2010-03-17","publication_year":2010,"doi":"10.1167/5.8.683","pubmed_id":null,"openalex_id":"https://openalex.org/W2090298970","source_url":"https://doi.org/10.1167/5.8.683","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:05","last_checked":"2026-08-09 08:25:55","bibtex":null,"source_record_id":"DOI:10.1167/5.8.683","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1167/5.8.683","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1167/5.8.683","source_url":"https://doi.org/10.1167/5.8.683","doi":"10.1167/5.8.683","pmid":"","publication_date":"2010-03-17","importer_version":"2.1.3","text_redistributed":false}},{"id":5345,"title":"Psilocybin slows binocular rivalry switching through serotonin modulation","authors":"O. Carter, John D. Pettigrew, Felix Hasler, Guy Wallis, Franz X. Vollenweider","journal":"Journal of Vision","publication_date":"2010-03-19","publication_year":2010,"doi":"10.1167/6.6.43","pubmed_id":null,"openalex_id":"https://openalex.org/W1983329325","source_url":"https://doi.org/10.1167/6.6.43","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:05","last_checked":"2026-08-09 08:25:55","bibtex":null,"source_record_id":"DOI:10.1167/6.6.43","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1167/6.6.43","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1167/6.6.43","source_url":"https://doi.org/10.1167/6.6.43","doi":"10.1167/6.6.43","pmid":"","publication_date":"2010-03-19","importer_version":"2.1.3","text_redistributed":false}},{"id":5313,"title":"Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations","authors":"Michael Kometer, André Schmidt, Lutz Jäncke, Franz X. Vollenweider","journal":"Open MIND","publication_date":"2013-01-01","publication_year":2013,"doi":null,"pubmed_id":null,"openalex_id":"https://openalex.org/W6929930661","source_url":"https://openalex.org/W6929930661","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology,Genomics","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:04","last_checked":"2026-08-09 08:25:54","bibtex":null,"source_record_id":"https://openalex.org/W6929930661","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"https://openalex.org/W6929930661","source_url":"https://openalex.org/W6929930661","doi":"","pmid":"","publication_date":"2013-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5287,"title":"P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI study","authors":"Rainer Kraehenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider","journal":"European Neuropsychopharmacology","publication_date":"2014-09-25","publication_year":2014,"doi":"10.1016/s0924-977x(14)70316-5","pubmed_id":null,"openalex_id":"https://openalex.org/W2329615882","source_url":"https://doi.org/10.1016/s0924-977x(14)70316-5","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Receptor Pharmacology,Emotional Processing","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:04","last_checked":"2026-08-09 08:25:53","bibtex":null,"source_record_id":"DOI:10.1016/s0924-977x(14)70316-5","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/s0924-977x(14)70316-5","source_url":"https://doi.org/10.1016/s0924-977x(14)70316-5","doi":"10.1016/s0924-977x(14)70316-5","pmid":"","publication_date":"2014-09-25","importer_version":"2.1.3","text_redistributed":false}},{"id":5267,"title":"The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-making","authors":"Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider","journal":"European Psychiatry","publication_date":"2015-03-01","publication_year":2015,"doi":"10.1016/s0924-9338(15)30017-1","pubmed_id":null,"openalex_id":"https://openalex.org/W563138297","source_url":"https://doi.org/10.1016/s0924-9338(15)30017-1","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Chronic Pain,Brain Imaging,Receptor Pharmacology,Emotional Processing,Healthy Volunteers,Drug Interactions","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:04","last_checked":"2026-08-09 08:25:53","bibtex":null,"source_record_id":"DOI:10.1016/s0924-9338(15)30017-1","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/s0924-9338(15)30017-1","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/s0924-9338(15)30017-1","source_url":"https://doi.org/10.1016/s0924-9338(15)30017-1","doi":"10.1016/s0924-9338(15)30017-1","pmid":"","publication_date":"2015-03-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5263,"title":"P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteers","authors":"Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, Milan Scheidegger, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider","journal":"European Neuropsychopharmacology","publication_date":"2015-09-01","publication_year":2015,"doi":"10.1016/s0924-977x(15)30364-3","pubmed_id":null,"openalex_id":"https://openalex.org/W2513457040","source_url":"https://doi.org/10.1016/s0924-977x(15)30364-3","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Chronic Pain,Pharmacology,Receptor Pharmacology,Healthy Volunteers","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:04","last_checked":"2026-08-09 08:25:53","bibtex":null,"source_record_id":"DOI:10.1016/s0924-977x(15)30364-3","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/s0924-977x(15)30364-3","source_url":"https://doi.org/10.1016/s0924-977x(15)30364-3","doi":"10.1016/s0924-977x(15)30364-3","pmid":"","publication_date":"2015-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5228,"title":"Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination task","authors":"O. Grimm, Rainer Krähenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider","journal":"European Neuropsychopharmacology","publication_date":"2016-10-01","publication_year":2016,"doi":"10.1016/s0924-977x(16)31070-7","pubmed_id":null,"openalex_id":"https://openalex.org/W2545855757","source_url":"https://doi.org/10.1016/s0924-977x(16)31070-7","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:03","last_checked":"2026-08-09 08:25:52","bibtex":null,"source_record_id":"DOI:10.1016/s0924-977x(16)31070-7","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/s0924-977x(16)31070-7","source_url":"https://doi.org/10.1016/s0924-977x(16)31070-7","doi":"10.1016/s0924-977x(16)31070-7","pmid":"","publication_date":"2016-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5021,"title":"Effects of psilocybin in relative and global cerebral blood flow and behavioural correlates","authors":"Nathalie M. Rieser, Ladina P Gubser, Franz X. Vollenweider, Meyer Lars, Katrin H. Preller","journal":"Neuroscience Applied","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1016/j.nsa.2022.100702","pubmed_id":null,"openalex_id":"https://openalex.org/W4313200870","source_url":"https://doi.org/10.1016/j.nsa.2022.100702","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:43","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2022.100702","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2022.100702","source_url":"https://doi.org/10.1016/j.nsa.2022.100702","doi":"10.1016/j.nsa.2022.100702","pmid":"","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5006,"title":"Investigating cue-reactivity as biomarker for treatment success in psilocybin-assisted therapy for alcohol use disorder","authors":"Nathalie M. Rieser, Ladina P Gubser, C. Rossgoderer Da Silva, Franz X. Vollenweider, Marcus Herdener, Katrin H. Preller","journal":"Neuroscience Applied","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1016/j.nsa.2022.100102","pubmed_id":null,"openalex_id":"https://openalex.org/W4220743600","source_url":"https://doi.org/10.1016/j.nsa.2022.100102","substance_tags":"psilocybin","topic_tags":"Addiction,Biomarkers","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:43","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2022.100102","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.nsa.2022.100102","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2022.100102","source_url":"https://doi.org/10.1016/j.nsa.2022.100102","doi":"10.1016/j.nsa.2022.100102","pmid":"","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4708,"title":"Associations between behavioral and neuronal changes in self-referential processing following a single, moderate dose of psilocybin in depressed patients","authors":"L. Belinger, Flora Moujaes, Robin von Rotz, Nathalie M. Rieser, Marcus Herdener, Franz X. Vollenweider, Katrin H. Preller","journal":"Neuroscience Applied","publication_date":"2024-01-01","publication_year":2024,"doi":"10.1016/j.nsa.2024.104768","pubmed_id":null,"openalex_id":"https://openalex.org/W4405621752","source_url":"https://doi.org/10.1016/j.nsa.2024.104768","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:44","last_checked":"2026-08-09 08:25:32","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2024.104768","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2024.104768","source_url":"https://doi.org/10.1016/j.nsa.2024.104768","doi":"10.1016/j.nsa.2024.104768","pmid":"","publication_date":"2024-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4655,"title":"Fallbeispiele zur Therapie der rezidivierenden Depression mit Psilocybin","authors":"Eva Maria Schindowski, Franz X. Vollenweider","journal":"Nervenheilkunde","publication_date":"2024-04-01","publication_year":2024,"doi":"10.1055/a-2283-0221","pubmed_id":null,"openalex_id":"https://openalex.org/W4396883294","source_url":"http://dx.doi.org/10.1055/a-2283-0221","substance_tags":"psilocybin","topic_tags":"Depression","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-08-09 08:25:30","bibtex":null,"source_record_id":"DOI:10.1055/a-2283-0221","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"http://dx.doi.org/10.1055/a-2283-0221","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1055/a-2283-0221","source_url":"http://dx.doi.org/10.1055/a-2283-0221","doi":"10.1055/a-2283-0221","pmid":"","publication_date":"2024-04-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4421,"title":"Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial","authors":"Nathalie M. Rieser, Raoul Bitar, Simon Halm, Christina Rossgoderer, Ladina P Gubser, Maeva Thévenaz, Yara Kreis, Robin von Rotz, Carlos Nordt, Monika Visentini, Flora Moujaes, Etna Engeli, Andres Ort, Erich Seifritz, Franz Xaver Vollenweider, Marcus Herdener, Katrin H. Preller","journal":"Universität Zürich, ZORA","publication_date":"2025-04-01","publication_year":2025,"doi":"10.5167/uzh-284304","pubmed_id":null,"openalex_id":"https://openalex.org/W7127080333","source_url":"https://doi.org/10.5167/uzh-284304","substance_tags":"psilocybin","topic_tags":"Addiction,Clinical Trial,Randomized Controlled Trial,Adverse Events,Toxicity","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:40","last_checked":"2026-08-09 08:25:22","bibtex":null,"source_record_id":"DOI:10.5167/uzh-284304","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.5167/uzh-284304","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.5167/uzh-284304","source_url":"https://doi.org/10.5167/uzh-284304","doi":"10.5167/uzh-284304","pmid":"","publication_date":"2025-04-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4395,"title":"595. Psilocybin-Assisted Therapy for Relapse Prevention in Alcohol Use Disorder: A RCT","authors":"Nathalie M. Rieser, Raoul Bitar, Halm Simon, Christina Rossgoderer, Ladina P Gubser, Maeva Thévenaz, Yara Kreis, Robin von Rotz, Carlos Nordt, Flora Moujaes, Etna Engeli, Andres Ort, Erich Seifritz, Franz X. Vollenweider, Katrin H. Preller","journal":"Biological Psychiatry","publication_date":"2025-04-09","publication_year":2025,"doi":"10.1016/j.biopsych.2025.02.834","pubmed_id":null,"openalex_id":"https://openalex.org/W4409280291","source_url":"https://doi.org/10.1016/j.biopsych.2025.02.834","substance_tags":"psilocybin","topic_tags":"Addiction,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:40","last_checked":"2026-08-09 08:25:21","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2025.02.834","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2025.02.834","source_url":"https://doi.org/10.1016/j.biopsych.2025.02.834","doi":"10.1016/j.biopsych.2025.02.834","pmid":"","publication_date":"2025-04-09","importer_version":"2.1.3","text_redistributed":false}},{"id":4248,"title":"Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigm","authors":"Milad Soltanzadeh, Zheng Wang, Shona G. Allohverdi, Colleen E. Charlton, André Schmidt, Franz Xaver Vollenweider, Andreea O. Diaconescu","journal":"Universität Zürich, ZORA","publication_date":"2025-11-05","publication_year":2025,"doi":"10.5167/uzh-292276","pubmed_id":null,"openalex_id":"https://openalex.org/W7130720501","source_url":"https://doi.org/10.5167/uzh-292276","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Healthy Volunteers","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:38","last_checked":"2026-08-09 08:25:15","bibtex":null,"source_record_id":"DOI:10.5167/uzh-292276","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.5167/uzh-292276","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.5167/uzh-292276","source_url":"https://doi.org/10.5167/uzh-292276","doi":"10.5167/uzh-292276","pmid":"","publication_date":"2025-11-05","importer_version":"2.1.3","text_redistributed":false}}],"total":93,"page":1,"per_page":20,"pages":5,"resource":"papers","filters":{"q":null,"author":"Franz X. Vollenweider","substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}